APMA has the resources you need to help you through every step of your career. With detailed information about MIPS and recent coding trends along with compliance guidelines and practice marketing materials, APMA has you covered whether you are just getting started in practice, preparing for retirement, or anywhere in between.
Today's podiatrist has the necessary education and training to treat all conditions of the foot and ankle and plays a key role in keeping America healthy and mobile while helping combat diabetes and other chronic diseases.
Your feet are excellent barometers for your overall health. Healthy feet keep you moving and active. They are quite literally your foundation. In this section, learn more about APMA Seal-approved and accepted products, proper foot care, common foot and ankle conditions, and how your podiatrist can help keep you and your feet healthy.
APMA is the only organization lobbying for podiatrists and their patients on Capitol Hill. As the voice of podiatric medicine to your legislators and regulators, APMA is active on a variety of critical issues affecting podiatry and the entire health-care system.
APMA recently wrote to Anthem, Centene, and Humana to address members’ concerns with these carriers denying properly coded at-risk foot care claims. After hearing from APMA, Anthem has agreed to revise its policy and follow current National Correct Coding Initiative (NCCI) policy. The change goes into effect at the end of the month and is enterprise-wide. APMA is scheduling a meeting the last week in July to gather more information about this policy change.
In the meantime, APMA will continue to push Centene and Humana to make similar changes to their policies.
The primary issue arises when a podiatric physician attempts to code both trimming and/or debriding of toenails (e.g., G0127, CPT 11719, 11720, 11721) and paring or cutting of benign hyperkeratotic lesions (e.g., corn or callus) (e.g., CPT 11055, 11056, 11057). According to APMA member podiatrists, these carriers are denying payment of CPT 11719, 11720, 11721, and G0127 based on both the nail procedures and callus procedures having been performed at the same encounter, regardless of the physician’s proper use of the NCCI modifiers 59 or X [ESPU], and regardless of the location of the hyperkeratotic lesions pared.
For more information about APMA’s advocacy efforts and for resources, visit www.apma.org/59toolkit.
APMA and CAC Engagement Coalition to Meet in Person With CMS
—
Learn More11400 Rockville Pike, Suite 220
Rockville, MD 20852
301-581-9200
Contact Us
Copyright © 2024 American Podiatric Medical Association